Physician profile
Christopher Newman
NPI 1407967185
$705.81
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $152 · 2021: $105 · 2022: $161.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $180.07 | 2019-2020 | |
| Mentor Worldwide LLC | $165.21 | 2021-2022 | |
| Allergan, INC. | $149.31 | 2019-2022 | |
| Tela Bio, INC. | $59.30 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $36.86 | 2019 | |
| Integra Lifesciences Corporation | $32.26 | 2019 | |
| Innovation Technologies INC | $25.22 | 2022 | |
| Merz North America, INC. | $24.70 | 2020 | |
| Endo Pharmaceuticals INC. | $18.76 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.